×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| KERALA AYURVEDA LTD. | 313.58 | -26.96 | 311.27 | -2.40 | 415.0 | 346.0 |
| VENUS REMEDIES LTD. | 1788.9 | 196 | 1768.6 | 14.66 | 413 | 14.8 |
| SMS Lifesciences India Ltd | 846.58 | 48.53 | 846.01 | 18.08 | 356 | 16.9 |
Kerala Ayurveda Limited, with Security Code 530163, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.8 | 15.8 | 15.3 | 15.0 | 15.8 | 18.7 | 17.2 | 17.0 | 15.3 | 20.0 |
| Expenses | 11.7 | 13.6 | 14.8 | 13.0 | 14.1 | 18.2 | 16.8 | 15.4 | 16.8 | 20.6 |
| Operating Profit | 1.1 | 2.3 | 0.5 | 2.1 | 1.8 | 0.6 | 0.5 | 1.6 | -1.4 | -0.6 |
| OPM % | 8.63% | 14.35% | 3.31% | 13.85% | 11.35% | 3.03% | 2.69% | 9.45% | -9.13% | -2.76% |
| Other Income | 0.0 | 0.0 | 2.9 | 0.0 | 0.1 | 0.7 | 0.1 | -0.3 | 0.3 | 0.4 |
| Interest | 1.2 | 1.0 | 1.1 | 1.2 | 1.4 | 0.4 | 0.5 | 1.5 | 0.4 | 0.3 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | -0.2 | 1.1 | -0.7 | 0.8 | 0.3 | 0.1 | -0.1 | 0.1 | -1.7 | -0.7 |
| Tax % | -25.2% | 25.2% | 25.2% | 163.1% | 25.1% | 25.1% | -115.2% | -77.9% | -25% | -24.3% |
| Net Profit | -0.2 | 0.8 | 1.6 | 2.0 | 0.2 | 0.5 | -0.3 | -0.7 | -1.3 | -0.5 |
| EPS in Rs | -0.14 | 0.78 | 1.75 | 2 | 0.26 | 0.55 | -0.02 | -0.81 | -1.01 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.0 | 23.4 | 23.8 | 23.8 | 26.2 | 26.3 | 27.4 | 27.5 | 31.9 | 31.1 |
| Expenses | 20.6 | 24.9 | 23.2 | 22.3 | 25.6 | 25.3 | 24.3 | 26.7 | 26.3 | 32.3 |
| Operating Profit | 2.4 | -1.6 | 0.7 | 1.5 | 0.5 | 1.0 | 3.1 | 0.8 | 5.5 | -1.2 |
| OPM % | 10.5% | -6.7% | 2.9% | 6.4% | 2% | 3.8% | 11.2% | 2.9% | 17.4% | -3.8% |
| Other Income | 0.1 | 2.9 | 0.1 | 0.2 | 0.8 | 0.2 | -0.2 | 0.2 | 0.6 | 0.2 |
| Interest | 1.0 | 1.3 | 1.3 | 1.5 | 0.7 | 0.6 | 1.7 | 0.5 | 0.7 | 0.4 |
| Depreciation | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 2.0 | 0.7 |
| Profit before tax | 1.2 | -3.1 | -0.7 | -0.1 | -0.2 | 0.3 | 1.3 | 0.2 | 3.5 | -2.1 |
| Tax % | 13.1% | -276.1% | -169.2% | -107.5% | 99.7% | 379.2% | 87% | 120.1% | 5% | -28% |
| Net Profit | 1.0 | -1.1 | 0.5 | -0.3 | 0.0 | -0.8 | 0.1 | 0.5 | 3.6 | -2.7 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 19% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 25% |
| TTM: | -435% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 52% |
| 3 Years: | 71% |
| 1 Year: | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 20% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 22% |
| TTM: | 209% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 52% |
| 3 Years: | 71% |
| 1 Year: | 17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|